Properties of blebbistatin for cardiac optical mapping and other imaging applications
about
A highly soluble, non-phototoxic, non-fluorescent blebbistatin derivative.Motor-driven marginal band coiling promotes cell shape change during platelet activation.Low-Cost Optical Mapping Systems for Panoramic Imaging of Complex Arrhythmias and Drug-Action in Translational Heart ModelsThe Myosin II Inhibitor, Blebbistatin, Ameliorates FeCl3-induced Arterial Thrombosis via the GSK3β-NF-κB Pathway.Toward panoramic in situ mapping of action potential propagation in transgenic hearts to investigate initiation and therapeutic control of arrhythmias.Construction and use of a zebrafish heart voltage and calcium optical mapping system, with integrated electrocardiogram and programmable electrical stimulation.The role of myosin II in glioma invasion: A mathematical model.Nesprin-2G, a Component of the Nuclear LINC Complex, Is Subject to Myosin-Dependent Tension.The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart.NADH changes during hypoxia, ischemia, and increased work differ between isolated heart preparations.Discovery of (S)-3'-hydroxyblebbistatin and (S)-3'-aminoblebbistatin: polar myosin II inhibitors with superior research tool properties.Probing the Electrophysiology of the Developing Heart.High-resolution Optical Mapping of the Mouse Sino-atrial Node.NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium.Recovering Actives in Multi-Antitarget and Target Design of Analogs of the Myosin II Inhibitor Blebbistatin.
P2860
Q27314690-D0E2D1C5-10F5-4F62-AE66-6865EDD7276DQ30566075-29EB8712-6E90-44E4-B102-6CEF57997904Q30839986-FA2F16C5-54BC-4600-9309-17FBEDE46A82Q33717776-1296FB94-C01E-42FA-9138-994591C780D8Q34148596-19095D3A-50B0-4929-B462-25F760D7996CQ35571811-ECC5050D-BD44-4D5D-B57E-F146DF9B9CA3Q36271552-92A2AFFF-CCFC-4D87-BF8F-9B9B14D98429Q36724244-B831FFC7-F036-4307-908C-320DB4E314ABQ37073023-F0D18001-F29B-48FC-8B97-699C071845A1Q37576157-613947D9-5272-44DC-9D68-358B72EB6450Q48216156-82F03EDE-4240-4851-AB60-58FB55411D01Q49258743-371F0E71-867C-4AA2-A293-9259D9A78257Q51057809-948BD66E-C651-41FD-9384-4BB8C26E463AQ54277572-985FE49A-3800-43E6-9204-92A3F163F5F9Q55240164-F69D45F2-B5E6-4327-B1DA-34EA5AF28E74
P2860
Properties of blebbistatin for cardiac optical mapping and other imaging applications
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@ast
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@en
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@nl
type
label
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@ast
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@en
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@nl
prefLabel
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@ast
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@en
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@nl
P2093
P2860
P50
P1433
P1476
Properties of blebbistatin for cardiac optical mapping and other imaging applications
@en
P2093
Ara Arutunyan
Matthew W Kay
Narine Sarvazyan
P2860
P2888
P304
P356
10.1007/S00424-012-1147-2
P577
2012-09-19T00:00:00Z
P5875
P6179
1012687630